MIT leaders say federal research cuts and falling grad enrollment forced tighter budgets and fewer admissions — a shift President Sally Kornbluth calls "a striking loss."

Humacyte cut roughly 25% of its staff as it trims spending and refocuses commercial efforts for Symvess while preparing for upcoming trial data.

State regulators approved Dana-Farber’s roughly $50.5M proton therapy center at Longwood, a compact ambulatory build aimed at expanding pediatric and adult access.

Google’s Project Suncatcher has moved from research into launch talks, and SpaceX may be a partner; prototypes are slated for early 2027 amid major technical questions.

Cisco raised its fiscal 2026 revenue forecast to $62.8–$63B and announced a restructuring that could cost up to $1B in pre‑tax charges, with local job impacts still unclear.

Goldman Sachs' operations chief says the bank will build a 'digital factory floor' of AI agents to automate back‑office work while saying overall headcount should stay largely unchanged.

Rocket Lab will acquire Motiv Space Systems, bringing the Pasadena team that built Perseverance’s robotic arm into Rocket Lab Robotics.

ACC and Central Texas school districts have launched a healthcare academy that lets ninth-graders earn industry credentials and stack them toward ACC degrees. The program is backed by more than $10 million in grants.

Anthropic is reportedly courting $30–$50B in fresh capital that could value the San Francisco AI firm near $1 trillion as Claude demand strains compute.

A millisecond 'nanochip' used with nerve grafts helped grow blood vessels and speed functional recovery in mice, Ohio State researchers report. The approach is promising but still preclinical.

UC San Diego won a $5M renewal for its NIH‑backed FIRST program, preserving cohort hiring, mentorship and grant support for early‑career biomedical researchers.

A viral TikTok shows a Milwaukee user editing a DoorDash meal photo with ChatGPT and collecting roughly $39 in account credit, reigniting worries about AI refund fraud.

Cambridge-founded OpenEvidence moved its HQ to Miami in 2025 and is expanding across Florida with backing from a national medical society and major investors.